A Third of Children Use Dietary Supplements. Here ’s Why Researchers Say That’s Concerning
A third of kids and adolescents under age 19 regularly take supplements like omega-3 fatty acids, multivitamins and melatonin, according to a new report. It’s a finding that researchers say is concerning because there is no proven benefit for healthy children taking supplements. The report, published Monday as a research letter in the journal JAMA Pediatrics, found that overall about a third of the young people surveyed used dietary supplements, with multivitamins being the most common. Use of supplements that primarily contained vitamins and minerals remained stable over time, but use of herbal, non-vitamin, or non-mineral supplements increased, driven by the use of melatonin for sleep and omega-3s. Report author Dima M. Qato, an assistant professor in the Department of Pharmacy Systems, Outcomes and Policy at the University of Illinois at Chicago, says parents should avoid giving their kids supplements if they do not have any nutritional deficiencies. “Dietary supplements have no proven benefits in healthy kids and have some known risks,” says Qato. “They are not strictly regulated and the quality of products is questionable.” The researchers say that the use of supplements among young people is concerning, since some of these products, like muscle building supplements, iron, calcium and vitamin D have been shown to be associated with heart-related health problems in some cases. MORE: Should I Take Nutrition Supplements? Young girls and women...
CONCLUSION: The results support the validity of a 4-factor structure of the LSEQ with 9-items with adequate internal consistency and divergent validity. PMID: 32601644 [PubMed - in process]
CONCLUSION: A clinical assessment of female patients with FM requires a multidisciplinary approach, and patients with excessive daytime sleepiness in particular are recommended to undergo polysomnography. The authors believe that the early detection and treatment of accompanying OSA will contribute not only to the quality of life, but also to the survival of patients with FM. PMID: 32601643 [PubMed - in process]
I'm still waiting on my biology quiz scores to make a final decision, but I am taking summer biology for the sole reason of being premed. However, I have realized that I am likely not doing very well in the class (or at least not as well as I would like) and that it is taking a serious toll on my mental health and sleep schedule (possibly because I am not studying very efficiently or consistently, or because I am just **** at biology). Heck, I took biology honors at the high school level in... Seeking Advice on How To Cope with Dropping Pre-Med
Publication date: Available online 30 June 2020Source: Journal of Neuroscience MethodsAuthor(s): H Kloefkorn, LM Aiani, A Lakhani, S Nagesh, A Moss, W Goolsby, JM Rehg, NP Pedersen, S Hochman
Abstract Arachnoid cysts are benign congenital malformations of the arachnoid which account for approximately 1.4% of the intracranial lesions. Although it is usually asymptomatic, it may be accompanied by headache, hydrocephalus and seizure. Psychiatric disorders associated with arachnoid cysts are rare. In this article, we present a giant arachnoid cyst with hypomania symptoms and marked cognitive impairment. A 44-year-old female patient was admitted to our outpatient clinic with a 4-year history of headache, nervousness and attention problems. Magnetic resonance imaging revealed a giant arachnoid cyst with a si...
CONCLUSION: In conclusion, treatment with SSRIs was significantly more associated with improvement in the clinical symptoms. Sexual side effects were more prevalent with SSRIs, but the effect on cognitive functions did not differ from agomelatine Despite the distinct, promising mechanism of action, agomelatine was not as effective as the SSRIs for the treatment of depression. PMID: 32594496 [PubMed - in process]
WEDNESDAY, July 1, 2020 -- Some behavioral sleep problems in early childhood are associated with the onset of mental health symptoms during early adolescence, according to a study published online July 1 in JAMA Psychiatry. Isabel...
The FDA on Tuesday approved the drug, a liquid oil branded as Dojolvi, to treat genetic fatty acid oxidation disorders that can kill babies in their sleep.
Sleep problems in early childhood may be linked to the development of certain mental health disorders in adolescence, according to new research.